[PHARMA] QoQ Quarter Result on 31-Mar-2017 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
16-May-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Mar-2017 [#1]
Profit Trend
QoQ- 2363.52%
YoY- 2.96%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 613,196 574,503 517,967 618,294 582,816 515,215 531,796 9.93%
PBT 19,866 15,271 10,150 27,777 4,069 19,923 21,487 -5.08%
Tax 2,222 -11,381 -399 -8,519 -4,969 -7,275 -5,846 -
NP 22,088 3,890 9,751 19,258 -900 12,648 15,641 25.79%
-
NP to SH 21,700 3,580 9,520 18,923 -836 13,061 14,995 27.85%
-
Tax Rate -11.18% 74.53% 3.93% 30.67% 122.12% 36.52% 27.21% -
Total Cost 591,108 570,613 508,216 599,036 583,716 502,567 516,155 9.43%
-
Net Worth 526,888 531,892 542,147 544,360 531,169 531,250 524,177 0.34%
Dividend
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Div 15,573 12,973 10,376 10,368 7,773 10,365 12,949 13.05%
Div Payout % 71.77% 362.37% 108.99% 54.79% 0.00% 79.37% 86.36% -
Equity
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Net Worth 526,888 531,892 542,147 544,360 531,169 531,250 524,177 0.34%
NOSH 259,821 259,821 259,400 259,219 259,377 259,146 258,981 0.21%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin 3.60% 0.68% 1.88% 3.11% -0.15% 2.45% 2.94% -
ROE 4.12% 0.67% 1.76% 3.48% -0.16% 2.46% 2.86% -
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
RPS 236.25 221.42 199.68 238.52 224.93 198.81 205.34 9.77%
EPS 8.36 1.38 3.67 7.30 -0.32 5.04 5.79 27.66%
DPS 6.00 5.00 4.00 4.00 3.00 4.00 5.00 12.88%
NAPS 2.03 2.05 2.09 2.10 2.05 2.05 2.024 0.19%
Adjusted Per Share Value based on latest NOSH - 259,219
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
RPS 42.55 39.86 35.94 42.90 40.44 35.75 36.90 9.93%
EPS 1.51 0.25 0.66 1.31 -0.06 0.91 1.04 28.13%
DPS 1.08 0.90 0.72 0.72 0.54 0.72 0.90 12.88%
NAPS 0.3656 0.369 0.3762 0.3777 0.3685 0.3686 0.3637 0.34%
Price Multiplier on Financial Quarter End Date
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Date 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 -
Price 4.60 4.14 4.58 4.89 5.30 5.58 5.50 -
P/RPS 1.95 1.87 2.29 2.05 2.36 2.81 2.68 -19.05%
P/EPS 55.02 300.05 124.80 66.99 -1,642.66 110.71 94.99 -30.44%
EY 1.82 0.33 0.80 1.49 -0.06 0.90 1.05 44.15%
DY 1.30 1.21 0.87 0.82 0.57 0.72 0.91 26.76%
P/NAPS 2.27 2.02 2.19 2.33 2.59 2.72 2.72 -11.32%
Price Multiplier on Announcement Date
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Date 27/02/18 15/11/17 16/08/17 16/05/17 21/02/17 21/11/16 19/08/16 -
Price 4.04 3.82 4.19 4.72 5.12 5.70 5.62 -
P/RPS 1.71 1.73 2.10 1.98 2.28 2.87 2.74 -26.90%
P/EPS 48.32 276.85 114.17 64.66 -1,586.88 113.10 97.06 -37.10%
EY 2.07 0.36 0.88 1.55 -0.06 0.88 1.03 59.05%
DY 1.49 1.31 0.95 0.85 0.59 0.70 0.89 40.86%
P/NAPS 1.99 1.86 2.00 2.25 2.50 2.78 2.78 -19.92%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment